Jennifer L. Keating

Jennifer Keating represents clients in a wide range of transactions and in general corporate law matters. Her transactional practice is focused on domestic and cross-border stock and asset acquisitions and divestitures, mergers, joint ventures and minority investments. She also advises clients in strategic commercial matters such as co-development agreements and other collaborative arrangements. Jennifer works with clients in a number of industries, including technology, financial services, chemicals, consumer products and manufacturing.

Jennifer is ranked as a leading Corporate/M&A lawyer in Chambers USA and has been recognized by The Deal as one of its “Top Women in Dealmaking”.

Jennifer is a partner in Mayer Brown’s Chicago office and co-leader of the firm’s global Corporate & Securities practice. Prior to joining Mayer Brown, she served as law clerk to the Honorable James B. Loken of the United States Court of Appeals for the Eighth Circuit.

• Represented Morningstar in various transactions, including its strategic alliance with AssetMark involving the sale of approximately $12 billion in assets from the Morningstar Wealth Turnkey Asset Management Platform, and Morningstar’s acquisition of S&P’s Leveraged Commentary & Data business and related family of leveraged loan indexes for up to $650 million.
• Represented Wolters Kluwer in various matters, including its $415 million acquisition of Registered Agent Solutions, Inc., its acquisition of Vanguard Software Corporation, a global provider of cloud-based integrated business planning solutions, its acquisition of eOriginal, a leading provider of cloud-based digital lending software, and the sale of its Corsearch trademark solutions business to Audax Private Equity.
• Represented Unilever in its acquisition of mens’ personal care brand Dr. Squatch and its acquisition of premium biotech haircare brand K18.
• Represented Hemlock Semiconductor in the acquisition of DuPont's trichlorosilanes (TCS) business, and the acquisition by Corning of DuPont's equity interest in Hemlock, for $725 million.

• The University of Chicago Law School, JD, with honors
  Topic Access Editor, The University of Chicago Law Review
• Cornell University, BA

• Illinois